Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2682 of 3330
Next
>>
>
67026 to 67050 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MDA-MB-453	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.00213	uM	7518.069	0.8362	0.7826	1.5543
MDA-MB-453	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.0107	uM	7518.069	0.7450	0.6549	1.5543
MDA-MB-453	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.0533	uM	7518.069	0.6409	0.5022	1.5543
MDA-MB-453	TNBC	Luminal	Sirolimus	MTOR	MTOR	0.267	uM	7518.069	0.5744	0.4000	1.5543
MDA-MB-453	TNBC	Luminal	Sirolimus	MTOR	MTOR	1.33	uM	7518.069	0.5377	0.3418	1.5543
MDA-MB-453	TNBC	Luminal	Sirolimus	MTOR	MTOR	6.67	uM	7518.069	0.4543	0.2038	1.5543
MDA-MB-453	TNBC	Luminal	Sirolimus	MTOR	MTOR	33.3	uM	7518.069	0.4226	0.1491	1.5543
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.000427	uM	7904.068	1.1649	1.2394	1.3499
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.00213	uM	7904.068	0.9294	0.8944	1.3499
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.0107	uM	7904.068	1.0282	1.0416	1.3499
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.0533	uM	7904.068	0.6590	0.4684	1.3499
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.267	uM	7904.068	0.7986	0.6930	1.3499
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	1.33	uM	7904.068	0.7637	0.6379	1.3499
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	6.67	uM	7904.068	0.8513	0.7751	1.3499
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	33.3	uM	7904.068	0.8241	0.7329	1.3499
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	167	uM	7904.068	0.4164	0.0450	1.3499
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.000427	uM	7909.068	1.2799	1.4215	1.2903
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.00213	uM	7909.068	0.8457	0.7563	1.2903
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.0107	uM	7909.068	1.1316	1.2011	1.2903
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.0533	uM	7909.068	0.6995	0.5161	1.2903
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.267	uM	7909.068	0.8743	0.8022	1.2903
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	1.33	uM	7909.068	0.7704	0.6339	1.2903
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	6.67	uM	7909.068	0.9695	0.9525	1.2903
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	33.3	uM	7909.068	0.3847	-0.0461	1.2903
MDA-MB-468	TNBC	Basal A	Sirolimus	MTOR	MTOR	167	uM	7909.068	0.0800	-0.7176	1.2903

|<
<<
Previous
Page 2682 of 3330
Next
>>
>
67026 to 67050 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)